THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial.

Jean-Christophe CorvolJean-Philippe AzulayBjörn BosseYves DauvilliersLuc DefebvreFabian KlostermannNorbert KovacsDavid MaltêteWilliam G OndoRajesh PahwaWerner ReinStéphane ThoboisMartin ValisAleksandar VidenovicOlivier Rascolnull null

Published in: Movement disorders : official journal of the Movement Disorder Society (2021)

THN102 was well tolerated and showed a signal of efficacy at the 200/2 dose, supporting further development for the treatment of EDS in PD. © 2021 International Parkinson and Movement Disorder Society.

Keyphrases

obstructive sleep apnea
sleep quality
study protocol
sleep apnea
phase iii
positive airway pressure
phase ii
randomized controlled trial
physical activity
body mass index
open label